Regenxbio Inc (FRA:RB0)
€ 11.8 0.2 (1.72%) Market Cap: 582.38 Mil Enterprise Value: 351.37 Mil PE Ratio: 0 PB Ratio: 1.62 GF Score: 65/100

Regenxbio Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 06:35PM GMT
Release Date Price: €31.4 (-3.86%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Hello.

Kenneth T. Mills
REGENXBIO Inc. - CEO, President & Director

Hi.

Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Okay, sorry. I think the music was a little bit longer than we thought. I'm sorry about -- everyone, we are a few minutes late. My name is Gena Wang. I'm mid-cap biotech analyst at the Barclays. I first hope everyone stay healthy and would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual healthcare conference possible.

With that, I would like to introduce our next speaker, Ken Mills, President and CEO from REGENXBIO. Ken, I will hand over to you.

Kenneth T. Mills
REGENXBIO Inc. - CEO, President & Director

Great. Thanks, Gena. And thanks, everyone, who's able to join and listen in today. I'll echo Gena's comments about keeping everyone well and safe. And also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot